company background image
FME logo

Fresenius Medical Care XTRA:FME Lagerbericht

Letzter Preis

€39.75

Marktkapitalisierung

€11.7b

7D

1.5%

1Y

-6.1%

Aktualisiert

07 Jun, 2024

Daten

Finanzdaten des Unternehmens +

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

FME Aktienübersicht

Die Fresenius Medical Care AG bietet Dialyse- und damit verbundene Dienstleistungen für Menschen mit Nierenerkrankungen in Deutschland, Nordamerika und international an.

FME fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends5/6

Fresenius Medical Care AG Wettbewerber

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Fresenius Medical Care
Historical stock prices
Current Share Price€39.75
52 Week High€49.62
52 Week Low€30.16
Beta0.87
1 Month Change2.79%
3 Month Change6.91%
1 Year Change-6.12%
3 Year Change-42.06%
5 Year Change-40.40%
Change since IPO142.62%

Aktuelle Nachrichten und Updates

What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

May 30
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

May 10
Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

Recent updates

What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

May 30
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

May 10
Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Feb 22
When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Feb 03
Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Jan 16
Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Dec 29
Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Nov 21
Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Oct 16
Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 28
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Aug 21
Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Jul 23
An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

Jul 09
Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

Jun 25
These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

May 07
What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

Apr 23
Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Mar 24
We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Feb 03
Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Jan 19
Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Jan 04
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Dec 17
Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Nov 08
Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Aktionärsrenditen

FMEDE HealthcareDE Markt
7D1.5%2.4%0.4%
1Y-6.1%7.5%4.4%

Rendite im Vergleich zur Industrie: FME unter dem Niveau der Branche German Healthcare, die im vergangenen Jahr eine Rendite von 3.9% erzielte.

Rendite vs. Markt: FME hinter dem Markt German zurück, der im vergangenen Jahr eine Rendite von 8.6 erzielte.

Preisvolatilität

Is FME's price volatile compared to industry and market?
FME volatility
FME Average Weekly Movement4.6%
Healthcare Industry Average Movement5.6%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.6%

Stabiler Aktienkurs: FME hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: FMEDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
1996117,128Helen Gizawww.freseniusmedicalcare.com

Die Fresenius Medical Care AG erbringt Dialyse- und damit verbundene Dienstleistungen für Menschen mit Nierenerkrankungen in Deutschland, Nordamerika und international. Das Unternehmen bietet Dialysebehandlungen und damit zusammenhängende Labor- und Diagnosedienstleistungen über ein Netzwerk von ambulanten Dialysekliniken an; Materialien, Schulungen und Patientenunterstützungsdienste, die klinische Überwachung, Nachsorge und die Organisation der Lieferung von Hilfsmitteln an den Wohnort des Patienten umfassen; sowie Dialysedienstleistungen im Rahmen von Verträgen mit Krankenhäusern in den Vereinigten Staaten für Patienten mit terminaler Niereninsuffizienz (ESRD) und für Patienten, die an akutem Nierenversagen leiden. Darüber hinaus entwickelt, produziert und vertreibt das Unternehmen verschiedene Gesundheitsprodukte, darunter Polysulfon-Dialysatoren, Hämodialyse-Maschinen, Peritonealdialyse-Cycler, Peritonealdialyse-Lösungen, Hämodialyse-Konzentrate, -Lösungen und -Granulate, Blutschläuche, Nieren-Arzneimittel, Systeme zur Wasseraufbereitung sowie akute kardiopulmonale und Apherese-Produkte.

Fresenius Medical Care AG's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Fresenius Medical Care im Vergleich zum Marktanteil des Unternehmens?
FME grundlegende Statistiken
Marktanteil€11.66b
Gewinn(TTM)€483.59m
Umsatz(TTM)€19.47b

24.1x

Kurs-Gewinn-Verhältnis

0.6x

Kurs-Umsatz-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
FME Gewinn- und Verlustrechnung (TTM)
Einnahmen€19.47b
Kosten der Einnahmen€14.52b
Bruttogewinn€4.95b
Sonstige Ausgaben€4.47b
Umsatz€483.59m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

Jul 30, 2024

Gewinn per Aktie (EPS)1.65
Bruttomarge25.42%
Nettogewinnspanne2.48%
Schulden/Eigenkapital-Verhältnis52.5%

Wie hat sich FME auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

3.0%

Aktuelle Dividendenrendite

72%

Ausschüttungsquote